Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor - Related Studies

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor

This study has been completed.

Study NCT00003211. Last updated on August 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Medulloblastoma
		Nervous System Neoplasms
		Neuroectodermal Tumors
		Neuroectodermal Tumors, Primitive

2	More general conditions related to this trial
		Glioma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases

3	Interventions listed in this trial
		amifostine trihydrate
		cisplatin
		cyclophosphamide
		filgrastim
		vincristine sulfate
		radiation therapy

4	Additional drug interventions recognized in this trial
		Amifostine
		Vincristine

5	More general drug interventions related to this trial
		Alkylating Agents
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Radiation-Protective Agents
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		St. Jude Children's Research Hospital
		National Cancer Institute (NCI)